Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wallis

Showing results (281-290 of 332) with videos related to

Pageof 34
Sort By:
The Journal of Molecular Diagnostics : JMD|October 21, 2005
Layered peptide arrays: high-throughput antibody screening of clinical samplesGallya Gannot, Michael A Tangrea, John W Gillespie, et al.
The Journal of Infectious Diseases|November 24, 1999
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapyC S Hirsch, Z Toossi, C Othieno, et al.
The Journal of Infectious Diseases|January 29, 2003
Whole blood bactericidal activity during treatment of pulmonary tuberculosisRobert S Wallis, Solange A Vinhas, John L Johnson, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Nature Reviews. Immunology|June 14, 2018
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D Simmons, Catherine M Stein, Chetan Seshadri, et al.
Communications Medicine|June 9, 2026
Deep learning approach for probabilistic pulmonary function estimation from chest X-ray and peak expiratory flow rateChristoph Killing, Maximilian Wekerle, Jayne S Sutherland, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosisSeon-Hee Cheon, Beate Kampmann, Amy G Hise, et al.
The Lancet. Respiratory Medicine|February 15, 2020
Post-tuberculosis mortality and morbidity: valuing the hidden epidemicMatthew Quaife, Rein M G J Houben, Brian Allwood, et al.
Plos One|February 4, 2022
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Pageof 34

Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
The Journal of Molecular Diagnostics : JMD|October 21, 2005
Layered peptide arrays: high-throughput antibody screening of clinical samplesGallya Gannot, Michael A Tangrea, John W Gillespie, et al.
The Journal of Infectious Diseases|November 24, 1999
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapyC S Hirsch, Z Toossi, C Othieno, et al.
The Journal of Infectious Diseases|January 29, 2003
Whole blood bactericidal activity during treatment of pulmonary tuberculosisRobert S Wallis, Solange A Vinhas, John L Johnson, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Nature Reviews. Immunology|June 14, 2018
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D Simmons, Catherine M Stein, Chetan Seshadri, et al.
Communications Medicine|June 9, 2026
Deep learning approach for probabilistic pulmonary function estimation from chest X-ray and peak expiratory flow rateChristoph Killing, Maximilian Wekerle, Jayne S Sutherland, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosisSeon-Hee Cheon, Beate Kampmann, Amy G Hise, et al.
The Lancet. Respiratory Medicine|February 15, 2020
Post-tuberculosis mortality and morbidity: valuing the hidden epidemicMatthew Quaife, Rein M G J Houben, Brian Allwood, et al.
Plos One|February 4, 2022
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Pageof 34